Literature DB >> 25791533

The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer.

Ulvi Murat Yuksel1, Gulay Dilek, Lutfi Dogan, Mehmet Ali Gulcelik, Ugur Berberoglu.   

Abstract

AIM: CSE1L is the human homologue to the yeast gene CSE1 and CSE1L is a gene related to cancer progression. Thus, CSE1L may regulate the invasion and metastasis of breast cancer. The aim of this study is to show the relationship between CSE1L and axillary lymph node metastasis.
METHODS: Sixty-six breast cancer patients were evaluated according to patient and tumor characteristics. Immunohistochemistry was carried out on formalin-fixed, paraffin-embedded archival breast tumor tissues. The results of CSE1L staining were analyzed according to the percentage of immunoreactive cells.
RESULTS: There were 29 patients without axillary lymph node metastasis and 37 patients with nodal metastasis. The mean age of the patients was 50.6 ± 11.3 years. Age, tumor size, nuclear grade and hormone receptor status were similar in the axillary lymph node positive and negative groups. There was a statistically significant relationship between cytoplasmic CSE1L expression and axillary lymph node metastasis. However, nuclear CSE1L expression did not have any effect on axillary lymph node metastasis.
CONCLUSIONS: Cytoplasmic CSE1L overexpression may be a valuable tool for prognosis of breast cancer in future.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25791533     DOI: 10.5301/tj.5000239

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916            Impact factor:   2.098


  6 in total

1.  Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1.

Authors:  Mei Ye; Ruigang Han; Jianwu Shi; Xunda Wang; Allan Z Zhao; Fanghong Li; Hao Chen
Journal:  Med Oncol       Date:  2020-04-08       Impact factor: 3.064

Review 2.  CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy.

Authors:  Ming-Chung Jiang
Journal:  Tumour Biol       Date:  2016-09-05

3.  CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells.

Authors:  Shunta Nagashima; Junichi Maruyama; Kaori Honda; Yasumitsu Kondoh; Hiroyuki Osada; Makiko Nawa; Ken-Ichi Nakahama; Mari Ishigami-Yuasa; Hiroyuki Kagechika; Haruhiko Sugimura; Hiroaki Iwasa; Kyoko Arimoto-Matsuzaki; Hiroshi Nishina; Yutaka Hata
Journal:  J Biol Chem       Date:  2021-05-20       Impact factor: 5.157

Review 4.  Organotropism: new insights into molecular mechanisms of breast cancer metastasis.

Authors:  Wenjing Chen; Andrew D Hoffmann; Huiping Liu; Xia Liu
Journal:  NPJ Precis Oncol       Date:  2018-02-16

5.  CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival.

Authors:  Dong-Dong Cheng; He-Chun Lin; Shi-Jie Li; Ming Yao; Qing-Cheng Yang; Cun-Yi Fan
Journal:  Sci Rep       Date:  2017-04-07       Impact factor: 4.379

6.  The role of CSE1L expression in cervical lymph node metastasis of larynx tumors.

Authors:  Tuncay Tunccan; Sertac Duzer; Gulay Dilek; Ulvi Murat Yuksel; Hasan Cetiner; Caner Kılıc; Ayca Ant; Arzu Betul Duran
Journal:  Braz J Otorhinolaryngol       Date:  2019-07-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.